Genentech vet Richard Ho creates Rype Health to disrupt biopharma's medical affairs operations

July 13, 2018

The growing need and opportunity to advance biopharma's go-to-market operations has led a biotech veteran to create a medical affairs-focused firm.  Richard Ho, a former long-time medical affairs director at Genentech, has created Rype Health, as founder and managing partner.  The promise of Rype Health is to disrupt the medical affairs space within the industry by applying a systems approach to optimize what has traditionally been a very fragmented and inefficient business model.  

 

Ho takes deep biopharma experience that began 15 years ago with Astrazeneca, that included field medical, US and Global medical affairs roles.  He later helped to build a medical strategy consulting division at healthcare agency Cline Davis & Mann.  He followed that with an 8 year run at Genentech in various medical affairs roles at the product, portfolio and functional team levels, and more recently led medical strategy and operations at Ultragenyx.

 

Please reload

Featured Posts

Adapting to Change in Medical Affairs

July 27, 2018

1/2
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Follow

©2018 by Rype Health